Silverstein, S. M. (2019). Bromfenac Ophthalmic Solution 0.07% Versus Nepafenac Ophthalmic Suspension 0.3% for Post-Cataract Surgery Inflammation: A Pilot Study of Identical Dosing Regimens with Pre-Surgical “Pulse” Dose. Ophthalmol Ther.
Chicago Style CitationSilverstein, Steven M. "Bromfenac Ophthalmic Solution 0.07% Versus Nepafenac Ophthalmic Suspension 0.3% for Post-Cataract Surgery Inflammation: A Pilot Study of Identical Dosing Regimens With Pre-Surgical “Pulse” Dose." Ophthalmol Ther 2019.
Cita MLASilverstein, Steven M. "Bromfenac Ophthalmic Solution 0.07% Versus Nepafenac Ophthalmic Suspension 0.3% for Post-Cataract Surgery Inflammation: A Pilot Study of Identical Dosing Regimens With Pre-Surgical “Pulse” Dose." Ophthalmol Ther 2019.